ACEGID - Nigeria

ACEGID
ACEGID
ACEGID
  • Verified
    Listing
  • +5Years
    With Us
Company name
ACEGID
Location
African Center of Excellence for Genomics of Infectious Diseases, Redeemer's University, Ede, Osun State, Nigeria PMB230
Contact number
Website address
Working hours
  • Monday: 8:00am-5:00pm
  • Tuesday: 8:00am-5:00pm
  • Wednesday: 8:00am-5:00pm
  • Thursday: 8:00am-5:00pm
  • Friday: 8:00am-5:00pm
  • Saturday: Closed
  • Sunday: Closed
Establishment year
2013
Employees
11-15
E-mail address
Company description
The African Centre of Excellence for Genomics of Infectious Diseases (ACEGID), based at Redeemer’s University, Nigeria, is focused on driving innovation in viral genomics research, diagnostic development, capacity building, and outbreak response. Established in 2013 and supported by the World Bank and the National Institutes of Health’s (NIH) H3Africa consortium, the ACEGID platform is building genomics pipelines, advancing our understanding of microbial threats, and training the next generation of African scientists how to identify, manage and control these threats.
Location map

Products & Services 3

  • Whole Genome Sequencing
    Technique that allows researchers to analyze the entire geno...
  • Polymerase Chain Reaction (PCR)
    Diagnostic technique that allows researchers to amplify cert...
  • Sanger Sequencing
    Technique that allows researchers to analyze a short segment...

Reviews

0 Reviews
0.0
 
Write a Review
This company has no reviews. Be the first to share your experiences!

Questions & Answers

Have questions? Get answers from ACEGID or BusinessList.com.ng users. Visitors haven’t asked any questions yet.

Verified Business

The accuracy of the company profile for ACEGID is validated by the company owner, representative, or directory administrator.
Last update on
Registered with us on

For security reasons this listing is locked from public updates. If you represent this company, please contact us directly.

Contact us
Share this listing
Send to WhatsApp Copy Link Share on Facebook Share on Linkedin